Pfizer said they expect to supply globally up to 50m vaccine doses in 2020 and up to 1.3bn doses in 2021.
Covid vaccine tracker: when will a coronavirus vaccine be ready?
“It is a relief to see such positive results on this vaccine and bodes well for Covid-19 vaccines in general.
Pfizer/BioNTech’s mRNA vaccine, which uses the genetic code rather than any part of the virus itself, has been one of the leaders in the global vaccine race.
The phase 3 trials have involved more than 43,000 people and are intended to establish whether the vaccine works.
The companies have a $1.95bn (£1.5bn) contract with the US government to deliver 100m vaccine doses beginning this year.
Low-income countries could face problems, however, because the vaccine needs ultra-cold chain; it must be stored at -70C. »